COVID-19 in lung transplant recipients—Risk prediction and outcomes
DLCO
Univariate analysis
Risk of mortality
DOI:
10.1371/journal.pone.0257807
Publication Date:
2021-10-06T20:51:32Z
AUTHORS (5)
ABSTRACT
Patients after lung transplantation are at risk for life-threatening infections. Recently, several publications on COVID-19 outcomes in this patient population appeared, but knowledge optimal treatment, mortality, outcomes, and appropriate predictors is limited. A retrospective analysis was performed a German high-volume transplant center between 19 th March 2020 18 May 2021. Impact of physical psychological health, clinical mortality were analyzed including follow-up visits up to 12 weeks infection survivors. Predictive parameters survival assessed using univariate multivariate proportional hazards regression models. Out 1,046 patients follow-up, 31 acquired during the pandemic. (39%) died 26 (84%) hospitalized . In survivors significant decline exercise capacity (p = 0.034), TLC 0.02), DLCO 0.007) observed 3 months. Anxiety, depression, self-assessed quality life remained stable. Charlson comorbidity index predicted (HR 1.5, 1.1–2.2; p 0.023). recipients with pre-existing CLAD, inferior. However, CLAD did not predict mortality. remains disease recipients, particularly case comorbidities. Further studies long term impact needed.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (26)
CITATIONS (49)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....